Ameritas Investment Partners’s Oyster Point Pharma, Inc. Common Stock OYST Stock Holding History

Ameritas Investment Partners’s Portfolio OYST Stock Details OYST Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q2	–	Sell	-485	Closed	-$6K	–	3339
2022 Q1	$6K	Hold	485	–	–	﹤0.01%	2954
2021 Q4	$9K	Hold	485	–	–	﹤0.01%	2940
2021 Q3	$6K	Hold	485	–	–	﹤0.01%	3026
2021 Q2	$8K	Hold	485	–	–	﹤0.01%	2966
2021 Q1	$9K	Hold	485	–	–	﹤0.01%	2910
2020 Q4	$9K	Hold	485	–	–	﹤0.01%	2856
2020 Q3	$10K	Hold	485	–	–	﹤0.01%	2738
2020 Q2	$14K	Hold	485	–	–	﹤0.01%	2556
2020 Q1	$17K	Hold	485	–	–	﹤0.01%	2276
2019 Q4	$12K	Buy	+485	New	+$8.51K	﹤0.01%	2673

Other funds holding OYST

NMC

NEA Management Company Timonium, Maryland $1.76B AUM 223.33% 1-Year Est. Return

IFA

Invus Financial Advisors New York $89.2M AUM 10.79% 1-Year Est. Return

RTW Investments New York $10B AUM 135.35% 1-Year Est. Return

Point72 Asset Management Stamford, Connecticut $78.1B AUM 55.25% 1-Year Est. Return

PBA

Paradigm Biocapital Advisors New York $4.89B AUM 251.12% 1-Year Est. Return

KKRC

Kohlberg Kravis Roberts & Co New York $5.35B AUM 63.01% 1-Year Est. Return

TAM

Telemark Asset Management Boston, Massachusetts $1.38B AUM 71.45% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

CAC

Cowen and Company New York $2.97B AUM 105.26% 1-Year Est. Return

Ameritas Investment Partners's OYST Position: Q2 2022 in Review

Ameritas Investment Partners sold out of Oyster Point Pharma, Inc. Common Stock (OYST) in Q2 2022, closing a stake of 485 shares — an estimated $6K sold.

Ameritas Investment Partners first reported a position in OYST in Q4 2019 and held it in 10 quarters. The position peaked at $17K in Q1 2020. 61 funds tracked by Wall St. Rank hold OYST as of Q2 2022.

Ameritas Investment Partners reported no remaining Oyster Point Pharma, Inc. Common Stock position as of Q2 2022 after selling out during the quarter.
Ameritas Investment Partners sold 485 Oyster Point Pharma, Inc. Common Stock shares in Q2 2022, an estimated $6K.
Ameritas Investment Partners first reported a position in Oyster Point Pharma, Inc. Common Stock in Q4 2019 and held it in 10 quarters.
Ameritas Investment Partners's Oyster Point Pharma, Inc. Common Stock position peaked at $17K in Q1 2020.
61 funds tracked by Wall St. Rank held Oyster Point Pharma, Inc. Common Stock as of Q2 2022.

Based on Ameritas Investment Partners's 13F filing for Q2 2022, filed 12 Aug 2022.